The Biological Products for Human Use market is a subset of the biopharmaceutical industry, which focuses on the development and production of drugs and other treatments derived from living organisms. These products are used to treat a variety of medical conditions, ranging from cancer to autoimmune diseases. Biological products are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create new proteins or other molecules. The Biological Products for Human Use market is highly regulated, with stringent safety and efficacy standards in place to ensure the safety of patients. Companies in this market must adhere to Good Manufacturing Practices (GMP) and other regulatory requirements in order to obtain approval from regulatory authorities. Some of the major companies in the Biological Products for Human Use market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
